Adverse Drug Reactions of Nicotinic Acid Injection

doi:10.19803/j.1672-8629.2020.12.13

Abstract

Abstract: Objective To analyze the characteristics and regularity of adverse drug reactions (ADR) caused by nicotinic acid injection in order to provide reference for clinical rational drug use.Methods The 1 174 ADR/AE of reported to the ADRS by fujian Province between January 2017 and December 2019 were analyzed using the retrospective study method.Results ADRs caused by nicotinic acid injection mostly occurred in the process of medication. These ADRs were mostly allergic reactions and angiectasis reactions and manifested themselves as the damage to the skin and its accessories, vascular damage and systemic damage.Conclusion We should strengthen the clinical monitoring of nicotinic acid injection, update the drug labeling without delay and promote the rational use of medicines so as to ensure the safety of medication.

Key words: nicotinic acid injection, adverse drug reactions, rational use of drugs

CLC Number:

R994.11

ZHANG Shu, LIN Qiang, DENG Wen, CHEN Shen. Adverse Drug Reactions of Nicotinic Acid Injection[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 907-912.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2020.12.13

https://www.zgywjj.com/EN/Y2020/V17/I12/907

References

[1] Committee of Experts on Rational Drug Use.China Pharmaceutical Reference[M].Chongqing:Chongqing press(重庆出版社),2009:628-629.
[2] Endocrinology and Metabolism Branch of Chinese Association of Geriatric Research,Committee of Clinical Toxicology of Chinese Society of Toxicology.Expert Consensus on Risk Management of Polypharmacy in Elderly[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2018,15(10):627-640.
[3] Sun DR,Qi P.Adverse drug reaction[M].Beijing:People's Medical Publishing House(人民卫生出版社),2003:9.
[4] Chen JX,Chen ZC.307 cases analysis of ADR in our hospital[J].Chinese Journal of Clinical Rational Drug Use(临床合理用药),2017,10(16):120-123.
[5] Chen GQ.A case of anaphylactic shock induced by nicotinic acid injection[J].Chinese Journal of Modern Applied Pharmacy(中国现代应用药学),2019,36(22):2864.
[6] Yang CC,Yu WQ,Han Y,et al.1 case report of adverse drug reaction caused by nicotinic acid sustained-release tablets[J].Pharmaceutical Journal of Chinese People's Liberation Army(解放军药学学报),2011,27(2):3.
[7] Lu Y,Ren JX,Li XC,et al.A case of hand numbness,chest tightness and dry cough caused by nicotinic acid injection[J].Chinese Journal of Drug Abuse Prevention and Treatment(中国药物滥用防治杂志),2019,25(2):120.
[8] Li J,Zhang HY.2 cases of new adverse drug reactions induced by nicotinic acid injection[J].Pharmaceutical Care and Research(药学服务与研究),2019,19(6):479-480.
[9] Wang D,Dong D.Exploration on Direct Reporting System of Adverse Drug Reactions by Marketing Authorization Holders[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2018,15(11):648-651.
[10] Sang Y,Wu SF,Lu CF,et al.Problems and Thoughts on Reporting and Monitoring of Adverse Drug Reactions in Drug Manuf-acturers[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2019,16(4):215-218.
[11] State Drug Administration.Notice on Revising the instruction manual of nicotinic acid injection[EB/OL].(2020-3-12) [2020-03-17].http://www.nmpa.gov.cn/WS04/CL2138/375843.html.

[1]	YU Jing, PALATI Reheman, ZHAO Ting, FENG Jirong, SUN Yan, HE Lei. Correlation of the efficacy, safety and plasma concentration of lacosamide in the treatment of children with epilepsy under 4 years of age [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 559-562.
[2]	YU Xin, GONG Leilei, YAO Weijie, YUAN Sisi, FENG Xin. Chinese patent medicines for recurrent spontaneous abortion: a scoping review of clinical evidence [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 361-365.
[3]	YANG Bo, WANG Mengjiao, HU Lili, WANG Laicheng, LI Qian, KONG Feifei, LYU Dongmei, SHEN Jiani. Safety assessment and risk factor analysis of PD-1 immunotherapy in a cohort of 385 patients [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 447-450.
[4]	LI haiyan, YANG Zhongxu, LIU Yuekun, WANG Lihong. Pharmaceutical care of serious adverse reactions due to methotrexate treatment of ectopic pregnancy [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 454-456.
[5]	LI Shaoqiang, KONG Xudong, LI Pengmei. One case of hyponatremia caused by omeprazole sodium for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 461-463.
[6]	WU Shiqi, YAN Suying, ZHANG Qingxia. Research progress in pharmacokinetic interactions of edoxaban [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 473-480.
[7]	YANG Xueting, HE Bo, YAN Hongli, LI Dongmei. One case of acute transient depression caused by clarithromycin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 352-354.
[8]	CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
[9]	GUO Longxin, GAO Yunjuan, WU Chengzhao, LONG Minjuan, ZHU Shengkai, SONG Haibo, ZHAO Xu, XIAO Xiaohe. Exploring new risk signals and susceptibility factors of traditional Chinese medicine-induced hepatotoxicity based on big data from adverse reaction monitoring [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 15-19.
[10]	JIANG Wenshuo, YANG Li. Adverse drug reaction among 694 patients in an epilepsy physician-pharmacist joint clinic [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 102-106.
[11]	CHEN Huayan, JIANG Dongbo, GUO Chunlian, YANG Jiaqi, LI Yuxin, CAI Weiming. Safety of nirmatrelvir/ritonavir in the treatment of novel coronavirus infections [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 107-110.
[12]	LI Xiaozhu, WANG Qiang, PANG Yu, ZHANG Yijing. Management of individual adverse drug reaction reports [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 975-977.
[13]	LIU Wendong, CUI Huanhuan, WANG Xiaohan, SU Xian, WANG Haixue. Status and thinking of Parmacovigilance regulatory system during clinical trials of the pediatric drug in China [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1002-1006.
[14]	ZANG Tianying, LIU Bingyang, TANG Xiaojun. Differentiation of vancomycin induced anaphylactoid and anaphylactic reactions [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1078-1080.
[15]	CHANG Yongzhuo, LI Ji, ZHANG Xiaoyan, ZHOU Chaofan. One case of abnormal uterine bleeding caused by Baofukang suppository [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 935-938.